FRESITA PROTEINS LIMITED
₹ 134
4.20%
08 Oct
- close price
- Market Cap ₹ 120 Cr.
- Current Price ₹ 134
- High / Low ₹ 175 / 60.0
- Stock P/E 43.3
- Book Value ₹ 96.0
- Dividend Yield 0.00 %
- ROCE 1.45 %
- ROE 1.02 %
- Face Value ₹ 10.0
Pros
- Company is almost debt free.
- Promoter holding has increased by 80.7% over last quarter.
Cons
- Though the company is reporting repeated profits, it is not paying out dividend
- Company has a low return on equity of 0.98% over last 3 years.
- Earnings include an other income of Rs.5.83 Cr.
- Working capital days have increased from 780 days to 1,729 days
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Loading peers table ...
Quarterly Results
Figures in Rs. Crores
Profit & Loss
Figures in Rs. Crores
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 5.02 | 2.06 | 6.18 | 5.65 | 7.22 | 5.40 | 11.36 | 10.76 | 5.80 | 1.30 | 24.18 | 16.16 | 18.19 | |
| 5.14 | 2.18 | 6.35 | 6.00 | 7.33 | 5.31 | 11.38 | 10.50 | 5.95 | 1.45 | 24.16 | 15.87 | 20.69 | |
| Operating Profit | -0.12 | -0.12 | -0.17 | -0.35 | -0.11 | 0.09 | -0.02 | 0.26 | -0.15 | -0.15 | 0.02 | 0.29 | -2.50 |
| OPM % | -2.39% | -5.83% | -2.75% | -6.19% | -1.52% | 1.67% | -0.18% | 2.42% | -2.59% | -11.54% | 0.08% | 1.79% | -13.74% |
| 0.80 | 0.00 | 0.00 | -0.01 | 0.03 | 0.08 | 0.08 | 0.09 | 0.16 | 0.17 | 0.00 | 0.35 | 5.83 | |
| Interest | 0.02 | 0.03 | 0.01 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Depreciation | 0.04 | 0.02 | 0.01 | 0.01 | 0.01 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Profit before tax | 0.62 | -0.17 | -0.19 | -0.37 | -0.09 | 0.17 | 0.06 | 0.35 | 0.01 | 0.02 | 0.02 | 0.64 | 3.33 |
| Tax % | 4.84% | -5.88% | -31.58% | -10.81% | 44.44% | 82.35% | 133.33% | 14.29% | 500.00% | 0.00% | 100.00% | 28.12% | |
| 0.59 | -0.15 | -0.13 | -0.33 | -0.12 | 0.03 | -0.02 | 0.31 | -0.03 | 0.02 | 0.01 | 0.45 | 2.78 | |
| EPS in Rs | 1.80 | -0.87 | -0.75 | -1.91 | -0.70 | 0.17 | -0.12 | 1.80 | -0.17 | 0.12 | 0.06 | 0.50 | 4.41 |
| Dividend Payout % | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Compounded Sales Growth | |
|---|---|
| 10 Years: | 23% |
| 5 Years: | 7% |
| 3 Years: | 41% |
| TTM: | -48% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | 17% |
| 5 Years: | 90% |
| 3 Years: | 157% |
| TTM: | 813% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | % |
| 5 Years: | 29% |
| 3 Years: | 48% |
| 1 Year: | 20% |
| Return on Equity | |
|---|---|
| 10 Years: | 0% |
| 5 Years: | 1% |
| 3 Years: | 1% |
| Last Year: | 1% |
Balance Sheet
Figures in Rs. Crores
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 2.43 | 2.50 | 2.50 | 2.50 | 2.50 | 2.50 | 2.50 | 2.50 | 2.50 | 2.50 | 2.50 | 9.75 |
| Reserves | 0.30 | 0.15 | 0.02 | -0.31 | -0.44 | -0.41 | -0.43 | -0.12 | -0.15 | -0.13 | -0.13 | 76.45 |
| 0.21 | 0.61 | 0.20 | 0.00 | 0.01 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| 0.20 | 0.21 | 0.20 | 0.13 | 0.12 | 0.06 | 0.07 | 0.07 | 0.05 | 0.07 | 0.27 | 0.45 | |
| Total Liabilities | 3.14 | 3.47 | 2.92 | 2.32 | 2.19 | 2.15 | 2.14 | 2.45 | 2.40 | 2.44 | 2.64 | 86.65 |
| 0.10 | 0.06 | 0.05 | 0.03 | 0.02 | 0.01 | 0.01 | 0.00 | 0.00 | 0.00 | 0.00 | 0.01 | |
| CWIP | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Investments | 0.01 | 0.01 | 0.01 | 0.01 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| 3.03 | 3.40 | 2.86 | 2.28 | 2.17 | 2.14 | 2.13 | 2.45 | 2.40 | 2.44 | 2.64 | 86.64 | |
| Total Assets | 3.14 | 3.47 | 2.92 | 2.32 | 2.19 | 2.15 | 2.14 | 2.45 | 2.40 | 2.44 | 2.64 | 86.65 |
Cash Flows
Figures in Rs. Crores
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -0.72 | -1.20 | -0.09 | 0.48 | -0.59 | -0.05 | -0.05 | 0.10 | -0.30 | -0.23 | -0.11 | -76.36 | |
| 1.90 | 0.20 | 0.00 | 0.02 | 0.11 | 0.09 | 0.08 | 0.09 | 0.16 | 0.17 | 0.00 | 0.36 | |
| -0.13 | 0.37 | -0.42 | -0.20 | 0.01 | -0.01 | 0.00 | 0.00 | 0.00 | 0.00 | 0.03 | 83.49 | |
| Net Cash Flow | 1.05 | -0.63 | -0.51 | 0.30 | -0.47 | 0.03 | 0.03 | 0.19 | -0.14 | -0.07 | -0.08 | 7.49 |
| Free Cash Flow | 0.73 | -1.18 | -0.09 | 0.48 | -0.59 | -0.04 | -0.05 | 0.10 | -0.30 | -0.23 | -0.11 | -76.35 |
| CFO/OP | 525% | 1,000% | 53% | -134% | 536% | -22% | 200% | 38% | 200% | 153% | -550% | -26,331% |
Ratios
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 13.81 | 0.00 | 38.98 | 44.58 | 36.40 | 56.10 | 24.74 | 7.12 | 0.00 | 0.00 | 0.00 | 93.51 |
| Inventory Days | 32.70 | 324.22 | 64.41 | 28.64 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Days Payable | 0.76 | 0.00 | 0.61 | 0.00 | ||||||||
| Cash Conversion Cycle | 45.75 | 324.22 | 102.78 | 73.22 | 36.40 | 56.10 | 24.74 | 7.12 | 0.00 | 0.00 | 0.00 | 93.51 |
| Working Capital Days | 65.44 | 251.60 | 108.08 | 76.23 | 83.92 | 114.91 | 55.91 | 64.45 | 130.27 | 603.65 | 5.89 | 1,729.23 |
| ROCE % | -5.93% | -4.52% | -6.02% | -14.66% | -5.63% | 8.17% | 2.88% | 15.73% | 0.42% | 0.85% | 0.84% | 1.45% |
Insights
In beta| Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Mustard Oil share of revenue % |
|
|||||||||
| Number of employees count |
||||||||||
| Number of products actively traded (with positive revenue) count |
||||||||||
| Solar Cell share of revenue % |
||||||||||
| Top product share of revenue % |
||||||||||
Requires Premium
Requires Premium
Extracted by Screener AI
Documents
Announcements
-
Shareholder Meeting / Postal Ballot-Scrutinizer''s Report
- Submitted scrutinizer report for AGM e-voting dated 30 September 2026.
-
Shareholder Meeting / Postal Ballot-Outcome of AGM
- Fresita Proteins held its 35th AGM on 30 September 2026; voting results pending.
- Closure of Trading Window
-
Clarificaion Of Price Movement
- Company denies any undisclosed material event behind recent share price movement.
-
CLARIFICATION FOR PRICE MOVEMENT
- Sarda Proteins replies to BSE price movement query, citing market forces and no undisclosed events.
Annual reports
-
Annual Report 2026
from bse
-
Annual Report 2025
from bse
-
Annual Report 2024
from bse
-
Annual Report 2023
from bse
-
Annual Report 2022
from bse
-
Annual Report 2021
from bse
-
Annual Report 2020
from bse
-
Annual Report 2019
from bse
-
Annual Report 2018
from bse
-
Annual Report 2017
from bse
-
Annual Report 2016
from bse
-
Annual Report 2015
from bse
-
Annual Report 2014
from bse
-
Annual Report 2013
from bse
-
Annual Report 2012
from bse
Business Overview:[1][2][3]
The co. historically dealt in protein and food products. In Sep 2024, it expanded its business objects to include solar-cell manufacturing, solar-power generation, and related machinery. In FY26, the operations remained primarily trading-led, centred on solar modules, photovoltaic components, and renewable
-energy equipment.
On Jul 15th 2026, the co. expanded its Objects Clause again to cover agriculture, horticulture, food processing, warehousing, and import and export. The disclosed agri-food model runs across sourcing, quality checks, storage, processing, and distribution. Its product scope includes dry fruits, nuts and seeds, pulses and grains, spices, edible oils, dairy products, and peanut-based foods. Processing operations are to be added through acquisitions.